Cardiovascular and sympathetic effects of reversing insulin resistance in hypertension.
Guido
G
Grassi
D002839:Chromans / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077288:Troglitazone